Validation and reproducibility of in vivo dosimetry for pencil beam scanned FLASH proton treatment in mice.

FLASH radiotherapy In vivo dosimetry Pencil beam scanning Proton therapy Small animal irradiation Ultra-high dose rate

Journal

Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology
ISSN: 1879-0887
Titre abrégé: Radiother Oncol
Pays: Ireland
ID NLM: 8407192

Informations de publication

Date de publication:
26 Jun 2024
Historique:
received: 14 03 2024
revised: 07 06 2024
accepted: 19 06 2024
medline: 29 6 2024
pubmed: 29 6 2024
entrez: 28 6 2024
Statut: aheadofprint

Résumé

To investigate quality assurance (QA) techniques for in vivo dosimetry and establish its routine uses for proton FLASH small animal experiments with a saturated monitor chamber. 227 mice were irradiated at FLASH or conventional (CONV) dose rates with a 250 MeV FLASH-capable proton beamline using pencil beam scanning to characterize the proton FLASH effect on abdominal irradiation and examining various endpoints. A 2D strip ionization chamber array (SICA) detector was positioned upstream of collimation and used for in vivo dose monitoring during irradiation. Before each irradiation series, SICA signal was correlated with the isocenter dose at each delivered dose rate. Dose, dose rate, and 2D dose distribution for each mouse were monitored with the SICA detector. Calibration curves between the upstream SICA detector signal and the delivered dose at isocenter had good linearity with minimal R In vivo dosimetry benefits FLASH experiments through enabling real-time dose and dose rate monitoring allowing mouse cohort regrouping when beam fluctuation causes delivered dose to vary from planned dose.

Identifiants

pubmed: 38942121
pii: S0167-8140(24)00674-1
doi: 10.1016/j.radonc.2024.110404
pii:
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

110404

Informations de copyright

Copyright © 2024 Elsevier B.V. All rights reserved.

Déclaration de conflit d'intérêts

Declaration of competing interest The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.

Auteurs

Alex Bookbinder (A)

New York Proton Center, New York, NY, USA.

Balaji Selvaraj (B)

New York Proton Center, New York, NY, USA.

Xingyi Zhao (X)

New York Proton Center, New York, NY, USA.

Yunjie Yang (Y)

Departments of Radiation Oncology and Medical Physics, Memorial Sloan Kettering Cancer Center, New York, NY, USA.

Brett I Bell (BI)

Department of Radiation Oncology, Montefiore Medical Center and Albert Einstein College of Medicine, Bronx, NY, USA; Department of Pathology, Albert Einstein College of Medicine, Bronx, NY, USA.

Michael Pennock (M)

Department of Radiation Oncology, Montefiore Medical Center and Albert Einstein College of Medicine, Bronx, NY, USA.

Pingfang Tsai (P)

New York Proton Center, New York, NY, USA.

Wolfgang A Tomé (WA)

Department of Radiation Oncology, Montefiore Medical Center and Albert Einstein College of Medicine, Bronx, NY, USA; Institute for Onco-Physics, Albert Einstein College of Medicine, Bronx, NY, USA.

J Isabelle Choi (J)

New York Proton Center, New York, NY, USA.

Chandan Guha (C)

Department of Radiation Oncology, Montefiore Medical Center and Albert Einstein College of Medicine, Bronx, NY, USA; Department of Pathology, Albert Einstein College of Medicine, Bronx, NY, USA; Institute for Onco-Physics, Albert Einstein College of Medicine, Bronx, NY, USA.

Charles B Simone (CB)

New York Proton Center, New York, NY, USA.

Haibo Lin (H)

New York Proton Center, New York, NY, USA.

Minglei Kang (M)

New York Proton Center, New York, NY, USA. Electronic address: mkang@nyproton.com.

Classifications MeSH